NASDAQ:AGIO

Agios Pharmaceuticals Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$40.50

-0.0900 (-0.222%)

At Close: Oct 08, 2024

Currently predicting for Wed, 9 Oct 2024

Trading levels for AGIO

Fibonacci Support & Resistance Levels

Level	Price
R3	41.70	2.96%
R2	41.35	2.10%
R1	41.14	1.57%
Price	40.50
S1	40.44	-0.142%
S2	40.23	-0.673%
S3	39.88	-1.53%

Accumulated Volume Support & Resistance Levels

Level	Price
R3	48.05	18.64%
R2	46.55	14.94%
R1	45.61	12.62%
Price	40.50
S1	0	-
S2	0	-
S3	0	-

AGIO Predictions History

1 year ago
JS predicted that AGIO for 2023-06-08 is going $26.86 (0.98%)

1 year ago
PredictionBot.Kathy predicted that AGIO for 2023-06-08 is going $26.64 (0.13%)

1 year ago
PredictionBot.Warren predicted that AGIO for 2023-06-08 is going $26.78 (0.69%)

5 years ago
NameNotImportant predicted that AGIO for 2019-04-29 is going $56.29 (-1.42%)

7 years ago
IM2Here predicted that AGIO for 2017-01-10 is going $38.00 (-11.17%)

Rank:

ABOUT AGIOS PHARMACEUTICALS

Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Ph...

Read Full Profile Here